Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on August 21, 2025
Neue Technologie zur Gesichtserkennung von Imprivata für schnelle, passwortlose Authentifizierung
GlobeNewswire
·
August 21, 2025
LANGENFELD, Deutschland, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Imprivata, ein führender Anbieter von Zugriffsmanagementlösungen für das Gesundheitswesen und andere geschäftskritische Branchen, hat eine fortschrittliche Gesichtserkennungstechnologie vorgestellt …
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
GlobeNewswire
·
August 21, 2025
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President …
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
GlobeNewswire
·
August 21, 2025
Achieving the primary endpoint in both Denali and the first NCX 470 Phase 3 trial, Mont Blanc, meets efficacy requirements for approval in the U.S. and China NCX 470 was also superior to latanoprost in the reduction of intraocular pressure (IOP) from …
Nicox annonce des résultats positifs pour NCX 470 dans l’étude de Phase 3 Denali chez des patients atteints de glaucome
GlobeNewswire
·
August 21, 2025
21 août 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que l’administration quotidienne en une seule …
Herantis Pharma releases 1H 2025 report today
GlobeNewswire
·
August 21, 2025
Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available at the Company’s …
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
August 21, 2025
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at an offering price of $0.52 per share and, to certain …
Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use
GlobeNewswire
·
August 21, 2025
SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 …
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
GlobeNewswire
·
August 21, 2025
MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated …